Primary Prevention
USPSTF statin recommendations for primary prevention mostly unchanged since 2016
The U.S. Preventive Services Task Force’s new recommendation statement on the use of statin therapy for primary prevention in adults aged 40 to 75 years with no history of CVD is similar to its 2016 recommendations.
Better primary, secondary prevention needed to reduce prehospital MI death
Prehospital deaths are a larger contributor to MI mortality, and how it varies within and across high-income countries, than hospital case fatality, highlighting a need for more early intervention efforts, data show.
Statin use for CVD may lower risk for COVID-19 hospitalizations, deaths
Statin use for primary prevention of CVD was associated with lower risk for COVID-19 hospitalizations and in-hospital deaths, according to findings from a cohort study published in the Journal of the American Heart Association.
Start early to treat risk factors in ‘pre-prediabetes,’ reduce complications
PHILADELPHIA — Insulin resistance and beta-cell failure begin long before a diagnosis of prediabetes and aggressive treatment should begin as early as possible to reduce risk for a variety of complications, according to a speaker.
CAC scoring valuable, can help decide CVD prevention strategies
PHILADELPHIA — Coronary artery calcium scoring is a helpful tool in patients aged 40 years or older whom a decision to start therapy for primary CVD prevention is not obvious, a speaker said at the Heart in Diabetes CME conference.
Reversing CVD trends requires focus on health equity, early interventions
PHILADELPHIA — CVD trends, particularly for HF, have gotten worse since 2011, and a way to address them may be to focus on health equity and begin prevention early, a speaker said at the Heart in Diabetes CME conference.
Q&A: ‘Primary prevention’ the biggest challenge in managing antiphospholipid syndrome
Reducing the risk for thrombotic events in patients with antiphospholipid syndrome means striking the proper balance of monitoring and anticoagulation therapy, according to Richard A. Furie, MD, of Northwell Health in New York.
USPSTF: No benefit of beta carotene, vitamin E, multivitamins in CVD, cancer prevention
The U.S. Preventive Services Task Force issued a recommendation statement against the use of beta carotene or vitamin E supplements for the prevention of CVD or cancer.
First, recurrent tachycardia less likely in women vs. men with primary prevention ICD
Women with HF who received an implantable cardioverter defibrillator for primary prevention were less likely to experience first and recurrent life-threatening ventricular tachycardias compared with men, researchers reported.
Lipid-lowering therapies underused for primary CVD prevention
In a cohort of more than 400,000 patients at high risk for CVD requiring primary prevention, less than half were taking appropriately dosed statins and less than 10% were taking nonstatin lipid-lowering therapies, researchers reported.